Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butylbromide for Shortening Labor Stages
NCT02839213Phase 2Completed
- Sponsor
- Woman's Health University Hospital
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyoscine butylbromide in labor, sponsored by Woman's Health University Hospital. Started Oct 2015; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
labor
Beyond the preview
Go deeper on NCT02839213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839213.